Company Overview

Cupid Limited is an Indian manufacturer of male condoms, female condoms, water-based lubricants, and personal care products. The company is recognized globally for its expertise in female condom manufacturing and exports its products to more than 100 countries through government agencies, NGOs, and international organizations.

Cupid primarily serves organizations such as the United Nations Population Fund, public health programs, and institutional buyers while gradually expanding its retail presence.

Fundamental Screener

Overall Fundamental Score

8.7/10 – Bullish

Financial Strength

Positives

✅ Debt-free or near debt-free balance sheet

✅ Healthy operating margins

✅ Strong return ratios

✅ Positive free cash flow

✅ High export contribution

✅ Consistent profitability

Concerns

• Relatively small market capitalization
• Revenue can fluctuate due to the timing of large institutional orders
• Customer concentration in government and NGO contracts
• Liquidity can be lower than larger healthcare companies

Bullish Factors

1. Global Export Business

Cupid exports to over 100 countries, reducing dependence on a single market and benefiting from global reproductive healthcare initiatives.

Bullish

2. Leadership in Female Condoms

The company is among the few manufacturers worldwide with expertise in female condoms, creating a niche competitive advantage and higher entry barriers.

3. Asset-Light & Debt-Free Business

A strong balance sheet with low debt allows Cupid to invest in capacity expansion and new product development without significant financial stress.

4. Expansion into Consumer Healthcare

Beyond institutional contracts, Cupid is increasing its focus on:

• Personal lubricants
• Retail condom brands
• E-commerce sales
• International consumer markets

These segments can improve revenue diversification.

5. High Return Ratios

Healthy ROE and ROCE indicate efficient use of capital and disciplined financial management.

Bearish Factors

1. Dependence on Institutional Orders

A meaningful portion of revenue comes from government agencies and global organizations. Delays or cancellations of tenders can affect quarterly performance.

2. Small-Cap Volatility

Cupid’s share price can experience significant swings due to lower trading volumes and market sentiment.

3. Competitive Industry

Competition from global healthcare companies and low-cost manufacturers can pressure pricing and market share.

4. Execution Risk

Success in expanding the consumer healthcare business depends on brand building, distribution, and marketing execution.

Technical Opinion

Bullish Scenario

The technical outlook improves if:

• Price sustains above major moving averages
• Breakouts are supported by strong volume
• Institutional buying increases
• Higher highs and higher lows continue

Trend: Bullish

Bearish Scenario

Monitor closely if:

• Price falls below long-term support levels
• Institutional selling intensifies
• Large export orders slow down
• Earnings growth weakens

Future Growth Drivers

✔ Export expansion

✔ Consumer healthcare products

✔ Female condom demand

✔ Government healthcare programs

✔ Capacity expansion

✔ New product launches

✔ International partnerships

SWOT Analysis

Bull Case (2026–2030)

If Cupid continues to:

• Expand exports,
• Diversify into consumer healthcare,
• Maintain healthy margins,
• Win institutional contracts, and
• Increase retail brand presence,

the company has the potential to deliver sustained earnings growth.

Long-Term Outlook: Bullish

Bear Case (2026–2030)

The outlook could weaken if:

• Large export tenders are delayed,
• Competition intensifies,
• Retail expansion underperforms,
• Revenue remains dependent on a few institutional customers.

Risk Level: Medium to High

Scenario-Based 5-Year Target